Ranjit Thakuria

Ranjit Thakuria

Auto-generated profile, based on publicly available information

Ranjit Thakuria

Department of Chemistry, Gauhati University, Guwahati 781014, Assam, India

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RTRanjit Thakuria
Ranjit Thakuria
ADAmit Delori
Amit Delori
WJWilliam Jones
William Jones
MLMaya P. Lipert
Maya P. Lipert
LRLilly Roy
Lilly Roy
NRNaír Rodríguez-Hornedo
Naír Rodríguez-Hornedo

4 January 2019 in Crystal Growth & Design
Verified
Journal Article
Closed access
RTRanjit Thakuria
Ranjit Thakuria
NNNaba K. Nath
Naba K. Nath
BSBinoy K. Saha
Binoy K. Saha

18 February 2018 in Crystals
Verified
Journal Article
Open access
PDF file
RTRanjit Thakuria
Ranjit Thakuria
BSBipul Sarma
Bipul Sarma
The pre-formulation of pharmaceutical cocrystals and salts is a concept of crystal engineering that has emerged as a promising technique for drug development in pharmaceutical industry. Recent introduction of pharmaceutical cocrystals in regulatory guidelines of US Food and Drug Administration (FDA) made them one of the potential alternatives when salt preparation is not feasible. Apart from generally regarded as safe (GRAS) coformers, drug‑drug and drug‑nutraceutical cocrystals are recent additions to pharmaceutical cocrystal family that have additional health benefits. Indeed, preparation of salt forms is a routine practice to deal with inadequacies associated with the active pharmaceutical ingredient (API) and happens to be a potentially reliable method. Amongst them, drug-drug and drug-nutraceutical cocrystals have drawn significant importance in the recent past as they reduce drug load and cost effects during multiple disease diagnosis. However, one has to be prudent in the selection of drug molecules, the presence of complementary hydrogen bond synthon, disease management during multiple disease therapy, etc. that play important roles in their preparation. That is the reason why drug–drug cocrystals are scarce in the literature compared to pharmaceutical cocrystals containing GRAS coformers and salt forms. Herein, we discuss case studies preferably the reported drug‑drug, drug‑nutraceutical cocrystals, and a few salts with an emphasis on their role in physicochemical property modulation.

18 March 2010 in Crystal Growth & Design
Verified
Journal Article
Closed access
NBN. Jagadeesh Babu
N. Jagadeesh Babu
SCSuryanarayan Cherukuvada
Suryanarayan Cherukuvada
RTRanjit Thakuria
Ranjit Thakuria
ANAshwini Nangia
Ashwini Nangia

28 July 2010 in Crystal Growth & Design
Verified
Journal Article
Closed access
SCSuryanarayan Cherukuvada
Suryanarayan Cherukuvada
RTRanjit Thakuria
Ranjit Thakuria
ANAshwini Nangia
Ashwini Nangia

28 July 2020 in Crystal Growth & Design
Verified
Journal Article
Closed access
TTTejender S. Thakur
Tejender S. Thakur
RTRanjit Thakuria
Ranjit Thakuria